Jenn Alton is a recognized leader in policy design and public health advocacy, bringing more than two decades of experience across senior corporate and federal government roles. She is widely respected in the federal government and across the biomedical community for her strategic insight, commitment to ethical leadership, and deep subject-matter expertise.
Jenn is known for offering clients something rare in Washington: clear-eyed guidance, integrity, and a relentless focus on results. She is the trusted advisor organizations turn to when they need to develop an effective advocacy strategy—and see it through to completion. Her approach emphasizes honesty, realism, and actionable policy solutions grounded in both political and operational feasibility.
“Trust is the foundation of everything we do. We build enduring relationships with clients and government leaders alike, partnering with a select group who share our values. By bringing order to complexity, we help turn bold ambitions into meaningful partnerships and results.”
Education and previous work
Jenn earned her Master of Public Policy from the UCLA Luskin School of Public Affairs and her Bachelors degree from Whittier College.
Coming to Washington as a Presidential Management Fellow, Jenn learned the art of budget formulation and legislative affairs at the Department of Health and Human Services (HHS), earning the Secretary’s Award for Distinguished Service. Jenn then served on Capitol Hill as Public Health Policy Director for the U.S. Senate Health, Education, Labor, and Pensions Committee for Senator Richard Burr. She led the development and negotiation of major public health legislation, including the bipartisan Pandemic and All-Hazards Preparedness Act, which strengthened the nation’s health security posture and created two cornerstone offices at HHS: the Biomedical Advanced Research and Development Authority (BARDA) and the Assistant Secretary for Preparedness and Response (ASPR).
In the biotechnology sector, Jenn led the establishment of the U.S. government affairs office for a multinational company developing vaccines for infectious diseases and cancer immunotherapies. As Vice President of Public Policy and Government Affairs, she oversaw federal policy strategy, political advocacy, public affairs, alliance development, and trade association engagement for eight years. Jenn then returned to the federal government to serve at HHS as a senior advisor to the ASPR, before launching PPG in 2019.
Jenn has completed executive leadership programs at Columbia Business School (High Impact Leadership) and the Wharton School (Pharmaceutical and Biotech Executives Leadership). She also serves as a member of the CSIS Bipartisan Alliance for Global Health Security.
Jenn’s top 5 StrengthsFinder themes are: Achiever, Relator, Responsibility, Deliberative, Futuristic